A new study raises fresh questions about the effectiveness of Gilead Sciences Inc’s anti-viral drug inhibitor in COVID-19 patients. A randomized, controlled trial of brake desivir in 584 moderately ill COVID-19 patients with pneumonia yielded disappointing results in research published on Friday in JAMA. Compared to standard care without brake …
Read More »
Gilead Sciences on Monday applied for approval from the U.S. Food and Drug Administration for its COVID-19 treatment, remdesivir. The biotech company also said the antiviral drug will go by the Veklury brand name in the US “Submitting today is a major milestone as we continue to work with the …
Read More »
Recent studies provide more information on what treatments do or do not work for COVID-19, with high-quality methods that provide reliable results. British researchers published their research on Friday on the only drug that has been shown to improve survival: a cheap steroid called dexamethasone. Two other studies found that …
Read More »
Some U.S. states facing an increase in coronavirus cases are now running out of patches, the only drug approved to treat COVID-19, while other parts of the country have an ample supply of life-saving drugs. The regional shortage is forcing doctors who are already struggling with an avalanche of cases …
Read More »
SAN ANTONIO – Twelve hospitals in the San Antonio area will receive 63 cases of the antiviral drug Remdesivir in an effort to help COVID-19 patients recover. This occurs after an increase in coronavirus cases over the past few weeks in the San Antonio area and in the state of …
Read More »